NAB2

NGFI-A binding protein 2

Basic information

Region (hg38): 12:57089043-57095476

Links

ENSG00000166886NCBI:4665OMIM:602381HGNC:7627Uniprot:Q15742AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NAB2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAB2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
20
clinvar
1
clinvar
21
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 20 1 1

Variants in NAB2

This is a list of pathogenic ClinVar variants found in the NAB2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-57089335-A-C not specified Uncertain significance (Jun 17, 2024)3298329
12-57091127-C-G not specified Uncertain significance (Feb 02, 2024)3172504
12-57091136-G-A not specified Uncertain significance (May 23, 2023)2549627
12-57091245-C-T Likely benign (Jan 01, 2023)2643108
12-57091246-G-A not specified Uncertain significance (Apr 23, 2024)3298328
12-57091354-G-C not specified Uncertain significance (Nov 10, 2022)2326081
12-57091477-G-A not specified Uncertain significance (Dec 28, 2023)3172472
12-57091486-G-C not specified Uncertain significance (Aug 23, 2021)2246815
12-57091502-G-A not specified Uncertain significance (Jan 05, 2022)2270331
12-57091511-G-C not specified Uncertain significance (Dec 13, 2022)2334139
12-57091631-C-T not specified Uncertain significance (Feb 06, 2023)2480915
12-57091658-C-G not specified Uncertain significance (Sep 26, 2024)3402432
12-57091661-C-T not specified Uncertain significance (Oct 12, 2021)2365720
12-57091672-C-T Benign (Jul 21, 2018)779440
12-57091718-C-G not specified Uncertain significance (Jul 30, 2023)2597561
12-57091738-G-T not specified Uncertain significance (Aug 15, 2024)3402431
12-57091769-G-A not specified Uncertain significance (Sep 12, 2023)2601553
12-57091801-C-T not specified Uncertain significance (Nov 15, 2023)3172499
12-57092578-C-A not specified Uncertain significance (Aug 13, 2021)2245188
12-57092955-A-G not specified Uncertain significance (Feb 12, 2024)3172444
12-57093080-C-A not specified Uncertain significance (Jul 26, 2024)3402430
12-57093118-A-G not specified Uncertain significance (Dec 13, 2023)3172447
12-57093187-A-C not specified Uncertain significance (Aug 31, 2022)2309977
12-57093514-G-A not specified Uncertain significance (Mar 07, 2024)3172458
12-57093524-G-A not specified Uncertain significance (Feb 27, 2023)2489537

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NAB2protein_codingprotein_codingENST00000300131 76583
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5670.433125737031257400.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.011683190.5260.00001973315
Missense in Polyphen36114.520.314361159
Synonymous-1.941621331.210.000007871145
Loss of Function3.30419.90.2010.00000118218

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.0001200.0000993
East Asian0.00005440.0000544
Finnish0.00005440.0000462
European (Non-Finnish)0.000.00
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional repressor for zinc finger transcription factors EGR1 and EGR2. Isoform 2 lacks repression ability (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.165

Intolerance Scores

loftool
rvis_EVS
-0.03
rvis_percentile_EVS
51.92

Haploinsufficiency Scores

pHI
0.734
hipred
Y
hipred_score
0.775
ghis
0.523

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.992

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nab2
Phenotype
normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
endochondral ossification;regulation of transcription, DNA-templated;nervous system development;cell population proliferation;Schwann cell differentiation;negative regulation of transcription by RNA polymerase III;myelination;regulation of epidermis development;positive regulation of tau-protein kinase activity
Cellular component
nucleus
Molecular function
transcription corepressor activity;protein binding;transcription factor binding;identical protein binding